Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ankle implant tracked for 5 years to see if it holds up

NCT ID NCT04944576

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study follows about 80 adults who receive the EasyMove total ankle prosthesis for severe ankle arthritis caused by injury, wear-and-tear, or rheumatoid arthritis. Researchers will monitor how often the implant loosens and needs revision, as well as pain, mobility, and function over five years. The goal is to see how well the device performs in everyday medical practice.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EasyMove total ankle prosthesis
What this could lead to
If successful, this study could confirm that the EasyMove ankle replacement is safe and works well over the long term for people with severe ankle arthritis.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Long-term complications like implant loosening or infection remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

82 people

The number who actually took part.

Started

Sep 2021

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients from participating centres will be enrolled as part of their clinical routine care.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient implanted with the studied device according to the instructions for use, for primary surgery in patients with ankle joints damaged by severe rheumatoid, post-traumatic or degenerative arthritis * Adult patient (≥18 years old) * Patient who received an information form and is willing to participate in the study Exclusion Criteria: * Contraindications listed in the instructions for use * Patient who is not able to express his/her non opposition

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ankle injuries and disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Raymond-Poincaré

    Garches, 92380, France

  • Centre Hospitalier Départemental Vendée

    La Roche-sur-Yon, 85925, France

  • Centre hospitalier universitaire vaudois

    Lausanne, CH-1011, Switzerland

  • Chu Brest

    Brest, 29609, France

  • Clinique Jouvenet

    Paris, 75016, France

  • Clinique Victor HUGO

    Paris, 75008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.